Companies: 10,795·Total market cap: $144.5T
Bioventus Inc.

Bioventus Inc.

BVSNASDAQHealthcare● Active
$9.00
$-0.04(-0.47%)
Market Cap$609549512
P/E Ratio—
52W High$11.249
52W Low$5.81
Cash on HandFinancialsRevenue

Bioventus Inc. (BVS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BVS · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$51.2M▲ +23.2% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$51.2M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+23.2%
vs prior fiscal year
Latest Quarter
$35.8M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$51.2MCash on Hand
Total Debt$311.3MTotal Debt
Net Cash / Net Debt−$260.1MNet Debt Position
Cash vs Debt Ratio
Cash 14%Debt 86%

Bioventus Inc. carries a net debt position of $260.1M. Total debt ($311.3M) exceeds cash on hand ($51.2M). Bioventus Inc. cash vs debt ratio: 14% cash / 86% debt.

Net Cash = Cash & ST Investments − Total Debt$51.2M − $311.3M = −$260.1M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
BVS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$51.2M+23.2%
Dec 31, 2024$41.6M+12.5%
Dec 31, 2023$37.0M+22.5%
Dec 31, 2022$30.2M-31.3%
Dec 31, 2021$43.9M-49.4%
BVS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Bioventus Inc.
Bioventus Inc.YOU
BVS
$51.2M8.4%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Bioventus Inc. (BVS) cash on hand as of December 31, 2025 is $51.2M, comprising $51.2M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Bioventus Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Bioventus Inc. cash reserves or cash position.

Bioventus Inc. annual cash on hand history shows increased +23.2% in 2025: increased +23.2% in 2025. Bioventus Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Bioventus Inc. carries total debt of $311.3M against cash of $51.2M, resulting in a net debt position of -$260.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

BVS cash on hand · 5 questions

As of December 31, 2025, Bioventus Inc. (BVS) has $51,238,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $51,238,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 28, 2026): $35,846,000. Data sourced from the annual 10-K filing via FMP.

BVS cash on handBVS cash reservesBVS cash 2025how much cash does BVS have

▸ Source: FMP /balance-sheet-statement · US GAAP · Bioventus Inc. · Bioventus Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025